Australia's Sonic Healthcare rises as Citi upgrades to 'neutral', says outperforms industry hurdles

Sonic Healthcare

20/03/2026 01:32

Updates

** Shares of Australia's Sonic Healthcare SHL.AX rise as much as 2.1% to A$21.00, set for their best day since February 26, if gains hold

** Citi upgrades the rating for Sonic Healthcare SHL.AX to "neutral" from "sell"

** "Risk-reward looks more balanced," says Citi

** Brokerage says the medical diagnostics services provider 'outperforms' industry backdrop in Australia in 1H26

** But flags potential underperformance in the U.S. business, cost pressures for co, and lowers PT to A$21.5 from A$22

** Five of 14 analysts rate the stock "buy" or higher, seven "hold" and two "sell" or lower; their median PT is A$25.3 – LSEG-compiled data

** SHL stock down 8.9%, YTD

 (Reporting by Aamir Sheik Khalid in Bengaluru)

 ((Aamir.SheikKhalid@thomsonreuters.com))